Abstract
This is a report on a case series of five patients with psychosis in Parkinson's disease who were treated successfully with an intramuscular injection of ziprasidone (10-20 mg) for acute agitation. No deterioration of motor function or other clinically relevant side effects were seen.
Copyright (c) 2005 John Wiley & Sons, Ltd.
MeSH terms
-
Aged
-
Antiparkinson Agents / therapeutic use
-
Antipsychotic Agents / administration & dosage
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / therapeutic use*
-
Electrocardiography
-
Emergency Medical Services
-
Female
-
Humans
-
Injections, Intramuscular
-
Male
-
Middle Aged
-
Parkinson Disease / complications*
-
Parkinson Disease / drug therapy
-
Parkinson Disease / psychology
-
Piperazines / administration & dosage
-
Piperazines / adverse effects
-
Piperazines / therapeutic use*
-
Psychiatric Status Rating Scales
-
Psychomotor Agitation / drug therapy
-
Psychomotor Agitation / etiology
-
Psychotic Disorders / drug therapy*
-
Psychotic Disorders / etiology*
-
Psychotic Disorders / psychology
-
Thiazoles / administration & dosage
-
Thiazoles / adverse effects
-
Thiazoles / therapeutic use*
Substances
-
Antiparkinson Agents
-
Antipsychotic Agents
-
Piperazines
-
Thiazoles
-
ziprasidone